Capstone Therapeutics Corp ( (CAPS) ) has released its Q2 earnings. Here is a breakdown of the information Capstone Therapeutics Corp presented to its investors.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Capstone Holding Corp., formerly known as Capstone Therapeutics Corp., is a holding company primarily operating through its subsidiary TotalStone, LLC, which distributes masonry stone products for residential and commercial construction across the Midwest and Northeast United States.
In its latest earnings report for the quarter ended June 30, 2025, Capstone Holding Corp. reported a slight decline in net sales compared to the previous year, alongside a net loss attributable to its stockholders. Despite these challenges, the company has made significant strides in restructuring and capital raising efforts, which include a recent public offering and a new securities purchase agreement.
Key financial metrics from the report indicate that Capstone experienced a net loss of $700,000 for the quarter, with net sales slightly decreasing to $12.85 million from $12.89 million in the same period last year. The company also reported a gross profit of $3.13 million, although selling, general, and administrative expenses increased, contributing to an operating loss. Notably, Capstone’s restructuring efforts included converting preferred units to common stock and securing new financing through a convertible note agreement.
Looking forward, Capstone Holding Corp. aims to leverage its recent capital restructuring and financing activities to strengthen its financial position and support its operational goals. The management remains focused on enhancing its product offerings and expanding its distribution network to drive future growth.